- Home
- ALLT vs ATAI Comparison
ALLT vs ATAI Comparison
Compare ALLT & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLT
- ATAI
- Stock Information
- Founded
- ALLT 1996
- ATAI 2018
- Country
- ALLT Israel
- ATAI Germany
- Employees
- ALLT N/A
- ATAI N/A
- Industry
- ALLT Telecommunications Equipment
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- ALLT Telecommunications
- ATAI Health Care
- Exchange
- ALLT Nasdaq
- ATAI Nasdaq
- Market Cap
- ALLT 349.3M
- ATAI 280.2M
- IPO Year
- ALLT 2006
- ATAI 2021
- Fundamental
- Price
- ALLT $6.77
- ATAI $1.99
- Analyst Decision
- ALLT Buy
- ATAI Strong Buy
- Analyst Count
- ALLT 1
- ATAI 4
- Target Price
- ALLT $13.00
- ATAI $9.00
- AVG Volume (30 Days)
- ALLT 824.9K
- ATAI 4.9M
- Earning Date
- ALLT 02-25-2025
- ATAI 03-27-2025
- Dividend Yield
- ALLT N/A
- ATAI N/A
- EPS Growth
- ALLT N/A
- ATAI N/A
- EPS
- ALLT N/A
- ATAI N/A
- Revenue
- ALLT $91,631,000.00
- ATAI $331,000.00
- Revenue This Year
- ALLT $0.41
- ATAI $80.07
- Revenue Next Year
- ALLT $8.84
- ATAI N/A
- P/E Ratio
- ALLT N/A
- ATAI N/A
- Revenue Growth
- ALLT N/A
- ATAI N/A
- 52 Week Low
- ALLT $1.78
- ATAI $1.03
- 52 Week High
- ALLT $9.44
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- ALLT 36.35
- ATAI 51.96
- Support Level
- ALLT $7.07
- ATAI $1.94
- Resistance Level
- ALLT $7.75
- ATAI $2.16
- Average True Range (ATR)
- ALLT 0.57
- ATAI 0.34
- MACD
- ALLT -0.29
- ATAI -0.03
- Stochastic Oscillator
- ALLT 1.11
- ATAI 48.38
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. It has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.